Q3 sales of continuing business rose +8% to €1,945m (total: -10% to €2,102m) and EBITDA was slightly up +2% to €287m (total: -21% to €243m). Net profit attributable to shareholders melted from €93m to €36m.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Nutrition’s back for good?
- Published:
03 Nov 2015 -
Author:
Martin Schnee -
Pages:
3
Q3 sales of continuing business rose +8% to €1,945m (total: -10% to €2,102m) and EBITDA was slightly up +2% to €287m (total: -21% to €243m). Net profit attributable to shareholders melted from €93m to €36m.